Inogen, Inc. (INGN)
6.25
-0.04
(-0.71%)
USD |
NASDAQ |
Oct 16, 16:00
6.16
-0.09
(-1.44%)
After-Hours: 20:00
Inogen Research and Development Expense (Annual) : 19.18M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 19.18M |
| December 31, 2024 | 21.40M |
| December 31, 2023 | 20.84M |
| December 31, 2022 | 21.94M |
| December 31, 2021 | 16.58M |
| December 31, 2020 | 14.08M |
| December 31, 2019 | 9.401M |
| December 31, 2018 | 7.029M |
| Date | Value |
|---|---|
| December 31, 2017 | 5.313M |
| December 31, 2016 | 5.113M |
| December 31, 2015 | 4.18M |
| December 31, 2014 | 2.977M |
| December 31, 2013 | 2.398M |
| December 31, 2012 | 2.262M |
| December 31, 2011 | 1.789M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Inspire Medical Systems, Inc. | 103.16M |
| Stryker Corp. | 1.567B |
| Zimmer Biomet Holdings, Inc. | 458.50M |
| Enovis Corp. | 120.33M |
| Edwards Lifesciences Corp. | 1.079B |